Transcript apt.rcpsych.org

Suggested guidelines for managing cardiovascular risk prior to and during treatment with
acetylcholinesterase inhibitors in Alzheimer’s disease. bpm, heartbeats per minute; the ‘drug’
means the chosen AChE inhibitor.
Jeremy P. Rowland et al. APT 2007;13:178-184
©2007 by The Royal College of Psychiatrists